Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI.
Laiz Laura de GodoyKheng Choon LimArchith RajanGaurav VermaMauro HanaokaDonald M O'RourkeJohn Y K LeeArati DesaiSeung-Cheol LeeSuyash MohanPublished in: Cancers (2023)
mutational status and 2HG may serve as a valuable diagnostic and prognostic biomarker in patients with gliomas.